Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing
Sign Up to like & getrecommendations! Published in 2017 at "HeartRhythm Case Reports"
DOI: 10.1016/j.hrcr.2017.07.009
Abstract: Introduction The clinical benefits of implantable cardioverter-defibrillator (ICD) therapy have been widely documented in clinical studies of selected patient populations. Subcutaneous ICD (S-ICD) is a valid alternative to transvenous ICDinpatientswhodonot require cardiac resynchronization or antibradycardia… read more here.
Keywords: inappropriate shocks; myopotential oversensing; implantable cardioverter; cardioverter defibrillator ... See more keywords